Home / 2014 / July (page 4)

Monthly Archives: July 2014

Geocaching Intro

geocache-image1

Groundspeak Inc. Free iOS/Android Summer provides a terrific opportunity for your patients to increase their levels of physical activity by getting outside. One unique way to motivate them might be "geocaching" which presents challenges to participants to collect "geocaches" by finding specific locations using their smart phones. There are millions …

Read More »

Letter from the Editor, #739

Each year when I talk to educators about the AADE meeting, I often find out that they can’t go because it is not their year. For most of them this means that their employer is only sending one or two educators a year and it is not their turn. If …

Read More »

Editor’s Note, DCMS #198

The mixing up of mixed insulins can cause problems for some of our patients especially if they are trying to achieve the best control possible. This week our Disaster Averted looks at what can happen when a patient is given the wrong analog. Our Clinical Text looks at the cost …

Read More »

NovoLog Mix 70/30 Confusion

When prescribing NovoLog® Mix 70/30 analog insulin, health care professionals may write an unclear prescription, or if using an EMR system, inadvertently select Novolin® 70/30 human insulin instead. Be on the lookout for these errors. Read on for a breakdown of the key differences between these 2 types of insulin. Before …

Read More »

Editor’s Note, Special GLP-1 Edition, July 2014

We know that patients lose a great deal of weight after bariatric surgery. Often times some of the weight comes off fast in the beginning and then slowly after that. More importantly these patients have a quick resolution of hyperglycemia and improvement in fasting, post prandial and hemoglobin A1c readings. …

Read More »

Gut Hormones and Bariatric Surgery

Human subjects with severe obesity are increasingly treated with bariatric surgery to promote weight loss via procedures that reduce the capacity of the stomach and/or the absorptive surface area of the small bowel, resulting in reduced food intake and/or energy malabsorption. Some of these surgical procedures may also be associated …

Read More »

Letter from the Editor, #738: Afrezza

After a long battle and comments from many doubters the FDA has approved the inhaled insulin, Afrezza. As soon as the approval came the nay-sayers were quick to remind us of what a failure Exubera had been and there was no way that this new inhaled insulin stood a chance. …

Read More »